6 research outputs found
Noninvasive Diagnosis of Kidney Dysfunction Using a Small-Molecule Manganese-Based Magnetic Resonance Imaging Probe
Contrast-enhanced
magnetic resonance imaging (CE-MRI) is a promising
approach for the diagnosis of kidney diseases. However, safety concerns,
including nephrogenic systemic fibrosis, limit the administration
of gadolinium (Gd)-based contrast agents (GBCAs) in patients who suffer
from renal impairment. Meanwhile, nanomaterials meet biosafety concerns
because of their long-term retention in the body. Herein, we propose
a small-molecule manganese-based imaging probe Mn-PhDTA as an alternative
to GBCAs to assess renal insufficiency for the first time. Mn-PhDTA
was synthesized via a simple three-step reaction with a total yield
of up to 33.6%, and a gram-scale synthesis can be realized. Mn-PhDTA
has an r1 relaxivity of 2.72 mM–1 s–1 at 3.0 T and superior kinetic inertness over
Gd-DTPA and Mn-EDTA with a dissociation time of 60 min in the presence
of excess Zn2+. In vivo and in
vitro experiments demonstrate their good stability and biocompatibility.
In the unilateral ureteral obstruction rats, Mn-PhDTA provided significant
MR signal enhancement, enabled distinguishing structure changes between
the normal and damaged kidneys, and evaluated the renal function at
different injured stages. Mn-PhDTA could act as a potential MRI contrast
agent candidate for the replacement of GBCAs in the early detection
of kidney dysfunction and analysis of kidney disease progression
Fabrication of Multifunctional Gd<sub>2</sub>O<sub>3</sub>/Au Hybrid Nanoprobe via a One-Step Approach for Near-Infrared Fluorescence and Magnetic Resonance Multimodal Imaging in Vivo
Facile
fabrication of multimodal imaging probes is highly desired
for bioimaging application due to their integrated advantages of several
imaging modalities. Here, we report a simple and one-step mild strategy
to fabricate a multifunctional Gd<sub>2</sub>O<sub>3</sub>/Au hybrid
nanoprobe. Bovine serum albumin (BSA) was used as the template in
the biomineralization synthesis. The fabricated BSA-Gd<sub>2</sub>O<sub>3</sub>/Au nanoprobe showed excellent chemical stability, intense
near-infrared (NIR) fluorescence, and good magnetic resonance imaging
(MRI) ability. The multimodal imaging potential of the prepared multifunctional
nanoprobe was demonstrated by successful NIR fluorescent and magnetic
resonance blood pool imaging. Further modification of BSA-Gd<sub>2</sub>O<sub>3</sub>/Au with arginine–glycine–aspartic acid
peptide cÂ(RGDyK) (RGD) enabled the nanoprobe for targeted tumor imaging
in vivo
Noninvasive Gastrointestinal Tract Imaging Using BSA-Ag<sub>2</sub>Te Quantum Dots as a CT/NIR-II Fluorescence Dual-Modal Imaging Probe in Vivo
The combination of high-resolution computed tomography
(CT) and
the real-time sensitive second near-infrared window (NIR-II) fluorescence
bioimaging can provide complementary information for the diagnosis,
progression and prognosis of gastrointestinal disorders. Ag2Te quantum dots (QDs) are a kind of promising CT/NIR-II fluorescence
dual-modal imaging probe due to their high atomic number and narrow
bandgap. However, conventional Ag2Te QDs synthesized by
oil phase approaches often suffer from complicated steps, harsh reaction
conditions, and toxic organic solvents. Herein, we report the synthesis
of bovine serum albumin (BSA)-Ag2Te QDs using a biomineralization
approach for CT/NIR-II fluorescence dual-modal imaging of the gastrointestinal
tract. The BSA-Ag2Te QDs are fabricated in a facile one-pot
approach under mild conditions and exhibit homogeneous size, favorable
monodispersity, admirable aqueous solubility, excellent X-ray attenuation
properties, and outstanding NIR-II fluorescence performance. In vivo
imaging experiments show that BSA-Ag2Te QDs can be used
in gastrointestinal tract CT/NIR-II dual-modal imaging with high spatiotemporal
resolution and sensitivity. In addition, in an intestinal obstruction
mouse model, accurate lesion positioning and imaging-guided obstruction
relief surgery are successfully realized based on BSA-Ag2Te QDs. Besides, BSA-Ag2Te QDs have outstanding biocompatibility
in vitro and in vivo. This study presents a high-performance and biosafe
CT/NIR-II fluorescence dual-modal imaging probe for visualizing the
gastrointestinal tract in vivo
Noninvasive Gastrointestinal Tract Imaging Using BSA-Ag<sub>2</sub>Te Quantum Dots as a CT/NIR-II Fluorescence Dual-Modal Imaging Probe in Vivo
The combination of high-resolution computed tomography
(CT) and
the real-time sensitive second near-infrared window (NIR-II) fluorescence
bioimaging can provide complementary information for the diagnosis,
progression and prognosis of gastrointestinal disorders. Ag2Te quantum dots (QDs) are a kind of promising CT/NIR-II fluorescence
dual-modal imaging probe due to their high atomic number and narrow
bandgap. However, conventional Ag2Te QDs synthesized by
oil phase approaches often suffer from complicated steps, harsh reaction
conditions, and toxic organic solvents. Herein, we report the synthesis
of bovine serum albumin (BSA)-Ag2Te QDs using a biomineralization
approach for CT/NIR-II fluorescence dual-modal imaging of the gastrointestinal
tract. The BSA-Ag2Te QDs are fabricated in a facile one-pot
approach under mild conditions and exhibit homogeneous size, favorable
monodispersity, admirable aqueous solubility, excellent X-ray attenuation
properties, and outstanding NIR-II fluorescence performance. In vivo
imaging experiments show that BSA-Ag2Te QDs can be used
in gastrointestinal tract CT/NIR-II dual-modal imaging with high spatiotemporal
resolution and sensitivity. In addition, in an intestinal obstruction
mouse model, accurate lesion positioning and imaging-guided obstruction
relief surgery are successfully realized based on BSA-Ag2Te QDs. Besides, BSA-Ag2Te QDs have outstanding biocompatibility
in vitro and in vivo. This study presents a high-performance and biosafe
CT/NIR-II fluorescence dual-modal imaging probe for visualizing the
gastrointestinal tract in vivo
Activatable Multifunctional Persistent Luminescence Nanoparticle/Copper Sulfide Nanoprobe for in Vivo Luminescence Imaging-Guided Photothermal Therapy
Multifunctional nanoprobes that provide
diagnosis and treatment
features have attracted great interest in precision medicine. Near-infrared
(NIR) persistent luminescence nanoparticles (PLNPs) are optimal materials
due to no in situ excitation needed, deep tissue penetration, and
high signal-to-noise ratio, while activatable optical probes can further
enhance signal-to-noise ratio for the signal turn-on nature. Here,
we show the design of an activatable multifunctional PLNP/copper sulfide
(CuS)-based nanoprobe for luminescence imaging-guided photothermal
therapy in vivo. Matrix metalloproteinases (MMPs)-specific peptide
substrate (H<sub>2</sub>N–GPLGVRGC–SH) was used to connect
PLNP and CuS to build a MMP activatable system. The nanoprobe not
only possesses ultralow-background for in vivo luminescence imaging
due to the absence of autofluorescence and optical activatable nature
but also offers effective photothermal therapy from CuS nanoparticles.
Further bioconjugation of cÂ(RGDyK) enables the nanoprobe for cancer-targeted
luminescence imaging-guided photothermal therapy. The good biocompatibility
and the multiple functions of highly sensitive tumor-targeting luminescence
imaging and effective photothermal therapy make the nanoprobe promising
for theranostic application
Facile Synthesis of Uniform-Sized Bismuth Nanoparticles for CT Visualization of Gastrointestinal Tract in Vivo
High-performance and biocompatible
contrast agents are the key to accurate diagnosis of various diseases
in vivo via CT imaging. Fabrication of pure Bi nanoparticles is the
best way to maximize X-ray absorption efficiency due to the ultrahigh
X-ray attenuation ability of Bi and 100% content of Bi element. However,
high-quality Bi nanoparticles prepared through a facile strategy are
still lacking. Herein, we report a simple noninjection method to fabricate
uniformly sized pure Bi nanoparticles using only two commercial reagents
by simply heating the mixture of raw materials in a short time. The
obtained Bi nanoparticles owned highly uniform size, excellent monodispersity,
and impressive antioxidant capacity. After being modified with oligosaccharide,
the “sweet” Bi nanoprobe with comfortable patient experience
and favorable biocompatibility was successfully used in CT visualization
of gastrointestinal tract in detail